Stefano Pretolani
Overview
Explore the profile of Stefano Pretolani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colina M, Pretolani S, Campana G
Age Ageing
. 2022 Oct;
51(10).
PMID: 36201328
No abstract available.
2.
Di Saverio S, Piccinini A, Birindelli A, Fabbri C, Pretolani S
BMJ
. 2017 Oct;
359:j4414.
PMID: 29025743
No abstract available.
3.
Zagari R, Romano M, Ojetti V, Stockbrugger R, Gullini S, Annibale B, et al.
Dig Liver Dis
. 2015 Aug;
47(11):903-12.
PMID: 26253555
Knowledge on the role of Helicobacter pylori (HP) infection is continually evolving, and treatment is becoming more challenging due to increasing bacterial resistance. Since the management of HP infection is...
4.
Arienti V, Aluigi L, Pretolani S, Accogli E, Polimeni L, Domanico A, et al.
Intern Emerg Med
. 2012 Oct;
7 Suppl 3:S283-90.
PMID: 23073869
Abdominal ultrasonography (US) represents the first-line imaging examination in chronic liver diseases; in most cases, US, laboratory findings and the clinical context are generally sufficient to guide the diagnosis. Thanks...
5.
Colina M, Bettoli V, Pretolani S, Zauli S, Govoni M, Arienti V
J Dermatol
. 2012 Jan;
39(7):659-60.
PMID: 22211732
No abstract available.
6.
Ramilli S, Pretolani S, Muscari A, Pacelli B, Arienti V
World J Gastroenterol
. 2009 Oct;
15(38):4770-4.
PMID: 19824109
Aim: To ascertain whether carotid lesions are more prevalent in outpatients with incidental findings of nonalcoholic fatty liver disease (NAFLD) at abdominal ultrasound (US). Methods: One hundred and fifty-four consecutive...
7.
Pacella C, Francica G, Di Lascio F, Arienti V, Antico E, Caspani B, et al.
J Clin Oncol
. 2009 Apr;
27(16):2615-21.
PMID: 19332729
Purpose: Percutaneous laser ablation (PLA) has been proposed as an active treatment in patients with hepatocellular carcinoma (HCC). However, large multicenter studies using this technique have not been reported. Patients...
8.
Arienti V, Pretolani S, Pacella C, Magnolfi F, Caspani B, Francica G, et al.
Radiology
. 2008 Jan;
246(3):947-55.
PMID: 18195382
Purpose: To retrospectively and prospectively determine the rate and type of complications and their association with clinical or technical factors after percutaneous laser ablation (LA) for hepatocellular carcinoma (HCC). Materials...
9.
Arienti V, Pretolani S, Goldberg S, Silverman S, Gervais D, Lencioni R, et al.
Radiology
. 2006 Oct;
241(2):625-6.
PMID: 17057081
No abstract available.